OPK
OPKO Health Reports Strong Q2 2026 Results, Advances Pipeline
OPKO Health, a global biopharmaceutical company, reported strong financial results for the second quarter of 2026 and made significant progress in advancing its product pipeline. In a recent conference call, the company's leadership provided an overview of its achievements and future plans. Dr. Philip Frost, Chairman and Chief